Observing Optimal Treatment Strategies in Ovarian Cancer in Ohio

We recently traveled to Columbus, Ohio for a State of the Science Summit on Ovarian Cancer. At the meeting, faculty from The Ohio University Comprehensive Cancer Center–James, discussed the importance of performing genetic testing upon diagnosis, shared insight on the evolution of ovarian cancer therapeutics, and provided perspective on individualized approaches in the frontline setting.

Additionally, panelists highlighted selection criteria for surgical procedures in ovarian cancer, contextualized the role of secondary surgery in the recurrent setting, and shed light on real-world evidence with PARP inhibitors in this space.